Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany,

Cornelia Adlhoch1, Marina Hoehne, Martina Littmann

  • 1Postgraduate Training for Applied Epidemiology, Robert Koch Institute, Berlin, Germany. adlhochc@rki.de

Insights

Rotavirus (RV) vaccination effectively protects infants from severe disease, with 68% effectiveness against medically attended infections. Breastfeeding and daycare attendance were linked to breakthrough RV infections in a German study.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Public Health Surveillance

Background:

  • Routine rotavirus (RV) vaccination recommended for infants in Mecklenburg-Western Pomerania since 2009.
  • Investigation prompted by high RV infection rates in fully vaccinated children.

Purpose of the Study:

  • Assess rotavirus vaccine effectiveness (VE) in infants.
  • Identify risk factors for breakthrough RV infections.

Main Methods:

  • Intensified RV surveillance from 2010-2011.
  • Case-control study and genotyping of vaccinated and unvaccinated children.
  • Screening method to assess VE up to 24 months post-vaccination.

Main Results:

  • VE was 68% for medically attended RV infection and 80% for hospitalization.
  • Vaccinated children had significantly lower hospitalization rates (23% vs 61%).
  • Breastfeeding (OR 3.99) and daycare (OR 3.42) associated with breakthrough infections.

Conclusions:

  • Rotavirus vaccination provides effective protection against RV disease and reduces severity.
  • Breastfeeding may potentially reduce vaccine effectiveness; further research is needed.
  • Specific RV genotypes showed differing associations with vaccine types (RotaTeq, Rotarix).
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...